Sign up for the premium plan and unlock all options
After purchasing the premium plan, you will unlock all information about drug prices and their availability.
Search
Listing 503561 - 503580 out of 505060 entries
| Country | ATC | Drug name | Drug form, strength, package | Price level | Price in € | Price in local currency | Therapeutic areas | Manufacturer / Importer |
|---|---|---|---|---|---|---|---|---|
| USA | (L01FX06) dinutuximab beta | UNITUXIN 3.5MG/ML INJ | 5ML | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | UnitedTherapeuticsCorporation |
| USA | (L01FX06) dinutuximab beta | UNITUXIN 3.5MG/ML INJ | 5ML | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | UnitedTherapeuticsCorporation |
| USA | (L01FX13) enfortumab vedotin | PADCEV 20MG/VIAL | 1 | Ex-factory price without vat |
$0-0 |
$0-0 |
Carcinoma, Transitional Cell;Urologic Neoplasms | PfizerInc. |
| USA | (L01FX13) enfortumab vedotin | PADCEV 20MG/VIAL | 1 | Ex-factory price without vat |
$0-0 |
$0-0 |
Carcinoma, Transitional Cell;Urologic Neoplasms | PfizerInc. |
| USA | (L01FX13) enfortumab vedotin | PADCEV 30MG/VIAL | 1 | Ex-factory price without vat |
$0-0 |
$0-0 |
Carcinoma, Transitional Cell;Urologic Neoplasms | PfizerInc. |
| USA | (L01FX13) enfortumab vedotin | PADCEV 30MG/VIAL | 1 | Ex-factory price without vat |
$0-0 |
$0-0 |
Carcinoma, Transitional Cell;Urologic Neoplasms | PfizerInc. |
| USA | (L01FX17) sacituzumab govitecan | TRODELVY | 1 | Ex-factory price without vat |
$0-0 |
$0-0 |
Breast Neoplasms;Triple Negative Breast Neoplasms | GileadSciences,Inc. |
| USA | (L01FX17) sacituzumab govitecan | TRODELVY | 1 | Ex-factory price without vat |
$0-0 |
$0-0 |
Breast Neoplasms;Triple Negative Breast Neoplasms | GileadSciences,Inc. |
| USA | (L01FX23) tisotumab vedotin | TIVDAK 40MG VIAL | 1 | Ex-factory price without vat |
$0-0 |
$0-0 |
Uterine Cervical Neoplasms | PfizerInc. |
| USA | (L01FX23) tisotumab vedotin | TIVDAK 40MG VIAL | 1 | Ex-factory price without vat |
$0-0 |
$0-0 |
Uterine Cervical Neoplasms | PfizerInc. |
| USA | (L01FX32) elranatamab | ELREXFIO 44MG/1.1ML INJ,SOLN | 1.1ML | Ex-factory price without vat |
$0-0 |
$0-0 |
Multiple Myeloma | PfizerInc. |
| USA | (L01FX32) elranatamab | ELREXFIO 44MG/1.1ML INJ,SOLN | 1.1ML | Ex-factory price without vat |
$0-0 |
$0-0 |
Multiple Myeloma | PfizerInc. |
| USA | (L01FX32) elranatamab | ELREXFIO 76MG/1.9ML INJ,SOLN | 1.9ML | Ex-factory price without vat |
$0-0 |
$0-0 |
Multiple Myeloma | PfizerInc. |
| USA | (L01FX32) elranatamab | ELREXFIO 76MG/1.9ML INJ,SOLN | 1.9ML | Ex-factory price without vat |
$0-0 |
$0-0 |
Multiple Myeloma | PfizerInc. |
| USA | (L01FX35) datopotamab deruxtecan | DATROWAY 100MG/VIAL INJ,LY | 1 | Ex-factory price without vat |
$0-0 |
$0-0 |
Breast Neoplasms | DaiichiSankyo,Inc. |
| USA | (L01FX35) datopotamab deruxtecan | DATROWAY 100MG/VIAL INJ,LY | 1 | Ex-factory price without vat |
$0-0 |
$0-0 |
Breast Neoplasms | DaiichiSankyo,Inc. |
| USA | (L01XA03) oxaliplatin | OXALIPLATIN INJECTION 5MG/ML 1X10ML GLASS | 10ML | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | TevaPharmaceuticalsUSA,Inc. |
| USA | (L01XA03) oxaliplatin | OXALIPLATIN INJECTION 5MG/ML 1X10ML GLASS | 10ML | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | TevaPharmaceuticalsUSA,Inc. |
| USA | (L01XA03) oxaliplatin | OXALIPLATIN INJECTION 5MG/ML 1X20ML GLASS | 20ML | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | TevaPharmaceuticalsUSA,Inc. |
| USA | (L01XA03) oxaliplatin | OXALIPLATIN INJECTION 5MG/ML 1X20ML GLASS | 20ML | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | TevaPharmaceuticalsUSA,Inc. |
Pages
